Barbara is the Clinical Data Manager for the ERGO/ISARIC Global Support Centre, currently focused on a global COVID-19 data research collaboration between ISARIC, University of Queensland and the COVID-19 Critical Care Consortium. The research collaboration focuses on COVID-19 patients undergoing ECMO (ExtraCorporeal Membrane Oxygenation). Barbara oversees the user management process, and the submission of quality clinical data from clinicians around the world participating in the collaboration. Prior to joining ERGO/ISARIC, Barbara worked in infectious diseases research, and as a scientist in vaccine and drug development.
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
Wainstein M. et al, (2022), PLoS medicine, 19
The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.
McLean ARD. et al, (2022)
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study.
Reyes LF. et al, (2022), ERJ open research, 8, 552 - 2021
The value of open-source clinical science in pandemic response: lessons from ISARIC
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Hall MD. et al, (2021), eLife, 10